|
Catalog Number 33550 |
Device Problem
Incorrect Measurement (1383)
|
Patient Problem
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 02/27/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Full patient identifier is case#: (b)(6).The customer did not provide patient demographics such as age, date of birth, weight, ethnicity or race.The customer did not supply a progesterone lot number; therefore, expiration date and udi are unavailable.The customer did not supply a progesterone lot number; therefore, date of manufacture is unavailable.The access reagent was not returned for evaluation.No hardware errors, flags or other assay issues were reported in conjunction with this event.A sample from the patient was forwarded to beckman coulter for investigative interference testing.The patient sample was first tested neat for the progesterone assay.The chaska chu (complaint handling unit) obtained a similar progesterone result as the customer.Then, a dilution testing was performed.Results did show the presence of interferences since the test results were not linear.Interference testing, using heterophile and alkaline phosphatase blocking agents was performed on the sample.Recovery was significantly reduced using the blocking agent (scavenger alp) for the progesterone assay.In conclusion, the likely cause of this event is the presence of a patient-source interferent.
|
|
Event Description
|
The customer reported erroneous progesterone (access progesterone, part number 33550 and lot number not provided) were generated on the customer's access 2 (access 2 immunoassay analyzer, part number 81600n and serial number: (b)(4) results were generated for one patient.The result of 1.10 ng/ml was released from the laboratory.There was a report of change to patient management in connection with this event.On (b)(6), 2023, the customer reported the patient was unable to receive treatment because her progesterone values were not in the correct range.Two written attempts were made to obtain additional information regarding the delay in treatment.To date, no additional information has been provided.The customer reported the progesterone result of 1.10 ng/ml did not align with results generated from a different analyzer.Customer was unable to provide additional information regarding alternate methodology or other results obtained.No hardware errors or issues with other assays were reported in connection with this event.No other patient results were called into question.No quality control failures were reported.Other system performance information such as system check and calibration were not provided for review.Sample collection and processing information such as sample type, sample volume collected, centrifugation speed and time and other sample processing information was not provided.The customer requested interference testing to be performed by the beckman coulter complaint handling unit (chu) and a patient sample was forwarded to chu for testing.
|
|
Search Alerts/Recalls
|
|
|